News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
115 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
3 (122)
4 (160)
5 (174)
6 (132)
9 (226)
10 (134)
11 (116)
12 (82)
13 (55)
16 (76)
17 (127)
18 (111)
19 (115)
20 (78)
23 (99)
24 (139)
25 (102)
26 (129)
27 (70)
30 (115)
31 (126)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
30
31
FDA
AbbVie Release: U.S. FDA Approves Imbruvica (Ibrutinib) As First Treatment Specifically Indicated For Relapsed/Refractory Marginal Zone Lymphoma (Mzl) - A Rare Type Of Non-Hodgkin’s Lymphoma
January 19, 2017
·
13 min read
Drug Development
Synthetic Biologics Release: Company Confirms Key Features Of Pivotal Phase 2b/3 Trial Of SYN-010 Pursuant To Consultations With FDA
January 19, 2017
·
7 min read
Biotech Beach
Biocept, Inc. Release: Company Awarded Patent In Australia For The Use Of Antibodies In Microchannels To Capture Circulating Tumor Cells And Other Rare Cells
January 19, 2017
·
4 min read
Cristal Therapeutics Release: Company Raises €12.8 Million In New Financing Round To Advance Novel Medicines Against Cancer Using Its CriPec Nanotech Platform
January 19, 2017
·
7 min read
Drug Development
Bristol-Myers Squibb Release: Company’s Opdivo (Nivolumab) Demonstrated Efficacy And Improved Survival In Patients With Previously Treated Advanced Gastric Cancer In A Randomized Phase III Study
January 19, 2017
·
19 min read
Genetown
InVivo Therapeutics Release: Company Announces New Patient Enrollment Into The INSPIRE Study
January 19, 2017
·
3 min read
Drug Development
BioTime Release: Additional Data From Company’s OpRegen Clinical Trial in Dry-AMD to be Presented At ARVO 2017
January 19, 2017
·
7 min read
Business
Bovie Medical Corporation Release: Company Announce Sales Channel Partnership With ConMed For PlazXact
January 19, 2017
·
2 min read
BioMidwest
5 Questions Medtech Needs to Ask Donald Trump
January 19, 2017
·
1 min read
BioMidwest
ViewRay Rakes in $26.1 Million in Private Placement
January 19, 2017
·
4 min read
Previous
4 of 12
Next
